BioCryst Pharmaceuticals, Inc. (BCRX)
6.72
+0.05
(+0.75%)
USD |
NASDAQ |
Jan 21, 16:00
6.79
+0.07
(+1.04%)
After-Hours: 20:00
BioCryst Pharmaceuticals Market Cap: 1.416B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Astria Therapeutics, Inc. | 713.56M |
| Hologic, Inc. | 16.75B |
| Bruker Corp. | 7.893B |
| Viatris, Inc. | 15.03B |
| KalVista Pharmaceuticals, Inc. | 804.19M |
Market Cap Related Metrics
| PS Ratio | 2.416 |
| Price to Free Cash Flow | 30.41 |
| Price | 6.72 |
| Earnings Yield | -0.70% |
| Operating PE Ratio | 19.04 |